Cancers with wrong HATs: the impact of acetylation

Lysine acetylation targets protein complexes and co-regulates major cellular functions

Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040 · see citing works

The Role of Chromatin during Transcription

Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,503 · see citing works

Mapping and analysis of chromatin state dynamics in nine human cell types

Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898 · see citing works

A decade of exploring the cancer epigenome—biological and translational implications

Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871 · see citing works

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,211 · see citing works

Cancer epigenomics: DNA methylomes and histone-modification maps

Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,150 · see citing works

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

Fraga, M. F., Ballestar, E., Villar‐Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C. E., Ropero, S., Petrie, K. R., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,926 · see citing works

CLINICAL CANCER RESEARCH

Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,796 · see citing works

Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family

Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J., Baršytė-Lovejoy, D., Felletár, I., Volkmer, R., Müller, S., Pawson, T. J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.013 · Cited by 1,719 · see citing works

Phenotypic plasticity and the epigenetics of human disease

Feinberg, A. P. (2007) · Nature · doi:10.1038/nature05919 · Cited by 1,613 · see citing works

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W.-I., Robson, S. C., Chung, C., Hopf, C., Savitski, M. M., et al. (2011) · Nature · doi:10.1038/nature10509 · Cited by 1,512 · see citing works

Genome-wide Map of Nucleosome Acetylation and Methylation in Yeast

Pokholok, D., Harbison, C. T., Levine, S. S., Cole, M. F., Hannett, N. M., Lee, T. I., Bell, G. W., Walker, K., Rolfe, A., Herbolsheimer, E., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.026 · Cited by 1,433 · see citing works

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

Peifer, M., Fernandez‐Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., Plenker, D., Leenders, F., Sun, R., Zander, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2396 · Cited by 1,390 · see citing works

Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes

Wang, Z., Zang, C., Cui, K., Schones, D. E., Barski, A., Peng, W., & Zhao, K. (2009) · Cell · doi:10.1016/j.cell.2009.06.049 · Cited by 1,344 · see citing works

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,337 · see citing works

MLL translocations, histone modifications and leukaemia stem-cell development

Krivtsov, A., & Armstrong, S. (2007) · Nature Reviews. Cancer · doi:10.1038/nrc2253 · Cited by 1,294 · see citing works

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

You, J. S., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.008 · Cited by 1,163 · see citing works

Global histone modification patterns predict risk of prostate cancer recurrence

Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M. R., & Kurdistani, S. K. (2005) · Nature · doi:10.1038/nature03672 · Cited by 1,090 · see citing works

TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity

Williams, K., Christensen, J., Pedersen, M. T., Johansen, J. V., Cloos, P. A. C., Rappsilber, J., & Helin, K. (2011) · Nature · doi:10.1038/nature10066 · Cited by 1,021 · see citing works

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09730 · Cited by 949 · see citing works

Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivation

Jin, Q., Yu, L., Wang, L., Zhang, Z., Kasper, L. H., Lee, J., Wang, C., Brindle, P. K., Dent, S. Y. R., & Ge, K. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.318 · Cited by 877 · see citing works

Comprehensive analysis of the chromatin landscape in Drosophila melanogaster

Kharchenko, P. V., Alekseyenko, A. A., Schwartz, Y. B., Minoda, A., Riddle, N. C., Ernst, J., Sabo, P. J., Larschan, E., Gorchakov, A. A., Gu, T., et al. (2010) · Nature · doi:10.1038/nature09725 · Cited by 853 · see citing works

Acetylation Is Indispensable for p53 Activation

Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838 · see citing works

CBP/p300-mediated acetylation of histone H3 on lysine 56

Das, C., Lucia, M. S., Hansen, K. C., & Tyler, J. K. (2009) · Nature · doi:10.1038/nature07861 · Cited by 698 · see citing works

p300/CBP and cancer

Iyer, N. G., Özdağ, H., & Caldas, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207118 · Cited by 645 · see citing works

CREBBP mutations in relapsed acute lymphoblastic leukaemia

Mullighan, C. G., Zhang, J., Kasper, L. H., Lerach, S., Payne-Turner, D., Phillips, L. A., Heatley, S. L., Holmfeldt, L., Collins-Underwood, J. R., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09727 · Cited by 628 · see citing works

SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation

Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R. I., Paredes, S., Young, N. L., Chen, K., et al. (2012) · Nature · doi:10.1038/nature11043 · Cited by 621 · see citing works

A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response

Masumoto, H., Hawke, D. H., Kobayashi, R., & Verreault, A. (2005) · Nature · doi:10.1038/nature03714 · Cited by 595 · see citing works

Mutations truncating the EP300 acetylase in human cancers

Gayther, S. A., Batley, S. J., Linger, L., Bannister, A. J., Thorpe, K. L., Chin, S., Daigo, Y., Russell, P. A., Wilson, A., Sowter, H., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587 · see citing works

Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-κB–Regulated Gene Products

Kunnumakkara, A. B., Guha, S., Krishnan, S., Diagaradjane, P., Gelovani, J. G., & Aggarwal, B. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4257 · Cited by 579 · see citing works

Epigenetic modifications in cancer

Kanwal, R., & Gupta, S. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01809.x · Cited by 551 · see citing works

Evidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways

Aoki, H., Takada, Y., Kondo, S., Sawaya, R. A., Aggarwal, B. B., & Kondo, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033167 · Cited by 523 · see citing works

Small Molecule Modulators of Histone Acetyltransferase p300

Balasubramanyam, K., Swaminathan, V., Ranganathan, A., & Kundu, T. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301580200 · Cited by 518 · see citing works

Global Levels of Histone Modifications Predict Prognosis in Different Cancers

Seligson, D. B., Horvath, S., McBrian, M. A., Mah, V. H., Yu, H., Tze, S., Wang, Q., Chia, D., Goodglick, L., & Kurdistani, S. K. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080874 · Cited by 511 · see citing works

H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells

Karmodiya, K., Krebs, A. R., Oulad‐Abdelghani, M., Kimura, H., & Tora, L. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-424 · Cited by 506 · see citing works

CBP and p300: HATs for different occasions

Kalkhoven, E. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.045 · Cited by 499 · see citing works

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications

Khan, O., & La Thangue, N. B. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.100 · Cited by 450 · see citing works

Structure and acetyl-lysine recognition of the bromodomain

Mujtaba, S., Zeng, L., & Zhou, M.-M. (2007) · Oncogene · doi:10.1038/sj.onc.1210618 · Cited by 419 · see citing works

Chromatin remodeling and cancer, part I: covalent histone modifications

Wang, G. G., Allis, C. D., & Chi, P. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.003 · Cited by 416 · see citing works

The MYST family of histone acetyltransferases and their intimate links to cancer

Avvakumov, N., & Côté, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210608 · Cited by 356 · see citing works

Screen for DNA‐damage‐responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells

Tjeertes, J. V., Miller, K. M., & Jackson, S. P. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.119 · Cited by 347 · see citing works

Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response

Gorrini, C., Squatrito, M., Luise, C., Syed, N., Perna, D., Wark, L., Martinato, F., Sardella, D., Verrecchia, A., Bennett, S., et al. (2007) · Nature · doi:10.1038/nature06055 · Cited by 341 · see citing works

Chromatin modifier enzymes, the histone code and cancer

Santos-Rosa, H., & Caldas, C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.010 · Cited by 336 · see citing works

DNA methylomes, histone codes and miRNAs: Tying it all together

Guil, S., & Esteller, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.005 · Cited by 317 · see citing works

Psammaplins from the Sponge Pseudoceratina purpurea: Inhibition of Both Histone Deacetylase and DNA Methyltransferase

Piña, I. C., Gautschi, J. T., Wang, G.-Y.-S., Sanders, M. L., Schmitz, F. J., France, D. S., Cornell-Kennon, S., Sambucetti, L. C., Remiszewski, S., Perez, L. B., et al. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo034248t · Cited by 314 · see citing works

Histone onco-modifications

Füllgrabe, J., Kavanagh, E. T., & Joseph, B. (2011) · Oncogene · doi:10.1038/onc.2011.121 · Cited by 307 · see citing works

Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

Wei, Y., Xia, W., Zhang, Z., Liu, J., Wang, H., Adsay, V. N., Albarracin, C. T., Yu, D., Abbruzzese, J. L., Mills, G. B., et al. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20413 · Cited by 303 · see citing works

p300 gene alterations in colorectal and gastric carcinomas.

Muraoka, M., Konishi, M., Kikuchi‐Yanoshita, R., Tanaka, K., Shitara, N., Chong, J., Iwama∥, T., & Miyaki, M. (1996) · PubMed · Cited by 282 · see citing works

Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer

Barlési, F., Giaccone, G., Gallegos-Ruiz, M. I., Loundou, A., Span, S. W., Lefesvre, P., Kruyt, F. A. E., & Rodríguez, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2599 · Cited by 280 · see citing works

Requirement of Hos2 Histone Deacetylase for Gene Activity in Yeast

Wang, A., Kurdistani, S. K., & Grunstein, M. R. (2002) · Science · doi:10.1126/science.1077790 · Cited by 272 · see citing works

Differential expression of selected histone modifier genes in human solid cancers

Özdağ, H., Teschendorff, A. E., Ahmed, A. A., Hyland, S. J., Blenkiron, C., Bobrow, L., Veerakumarasivam, A., Burtt, G. J., Subkhankulova, T., Arends, M. J., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-90 · Cited by 258 · see citing works

Cancer genetics of epigenetic genes

Miremadi, A., Oestergaard, M. Z., Pharoah, P. D. P., & Caldas, C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm021 · Cited by 249 · see citing works

The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation

Wang, L., Gural, A., Sun, X.-J., Zhao, X., Perna, F., Huang, G., Hatlen, M. A., Vu, L., Liu, F., Xu, H., et al. (2011) · Science · doi:10.1126/science.1201662 · Cited by 242 · see citing works

Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines

Santer, F. R., Höschele, P. P. S., Oh, S. J., Erb, H. H. H., Bouchal, J., Cavarretta, I. T. R., Parson, W., Meyers, D. J., Cole, P. A., & Čulig, Z. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0182 · Cited by 236 · see citing works

Activation of AML1‐mediated transcription by MOZ and inhibition by the MOZ–CBP fusion protein

Kitabayashi, I., Aikawa, Y., Nguyen, L. A., Yokoyama, A., & Ohki, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7184 · Cited by 235 · see citing works

Epigenetic Reprogramming by Adenovirus e1a

Ferrari, R., Pellegrini, M. A., Horwitz, G. A., Xie, W., Berk, A. J., & Kurdistani, S. K. (2008) · Science · doi:10.1126/science.1155546 · Cited by 230 · see citing works

MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP

Deguchi, K., Ayton, P. M., Carapeti, M., Kutok, J. L., Snyder, C. S., Williams, I. R., Cross, N. C. P., Glass, C. K., Cleary, M. L., & Gilliland, D. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00051-5 · Cited by 224 · see citing works

p300 in prostate cancer proliferation and progression.

Debes, J. D., Sebo, T. J., Lohse, C. M., Murphy, L. M., Haugen, D. A. L., & Tindall, D. J. (2003) · PubMed · Cited by 219 · see citing works

Acetylation-Dependent Regulation of Skp2 Function

Inuzuka, H., Gao, D., Finley, L. W. S., Yang, W., Wan, L., Fukushima, H., Chin, Y. R., Zhai, B., Shaik, S., Lau, A. W., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.038 · Cited by 218 · see citing works

Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704

Manuyakorn, A., Paulus, R., Farrell, J. J., Dawson, N. A., Tze, S., Cheung-Lau, G. C., Hines, O. J., Reber, H. A., Seligson, D. B., Horvath, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5639 · Cited by 216 · see citing works

Adenovirus Small e1a Alters Global Patterns of Histone Modification

Horwitz, G. A., Zhang, K., McBrian, M. A., Grunstein, M. R., Kurdistani, S. K., & Berk, A. J. (2008) · Science · doi:10.1126/science.1155544 · Cited by 209 · see citing works

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

Yang, G., Ayala, G., Marzo, A. D., Tian, W., Frolov, A., Wheeler, T. M., Thompson, T. C., & Harper, J. W. (2002) · PubMed · Cited by 203 · see citing works

Specific Inhibition of p300-HAT Alters Global Gene Expression and Represses HIV Replication

Mantelingu, K., Reddy, B. A., Swaminathan, V., Kishore, A. H., Siddappa, N. B., Kumar, G. V. P., Nagashankar, G., Natesh, N., Roy, S., Sadhale, P. P., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.04.011 · Cited by 193 · see citing works

Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead

Mai, A., & Altucci, L. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.020 · Cited by 190 · see citing works

Epigenetic Changes in Cancer

Iacobuzio–Donahue, C. A. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151442 · Cited by 188 · see citing works

Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancerPreprint

Valdés‐Mora, F., Song, J. Z., Statham, A. L., Strbenac, D., Robinson, M. D., Nair, S. S., Patterson, K., Tremethick, D. J., Stirzaker, C., & Clark, S. J. (2011) · Genome Research · doi:10.1101/gr.118919.110 · Cited by 186 · see citing works

The Global Histone Modification Pattern Correlates with Cancer Recurrence and Overall Survival in Gastric Adenocarcinoma

Park, Y. S., Jin, M. Y., Kim, Y. J., Yook, J. H., Kim, B. S., & Jang, S. J. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9927-9 · Cited by 182 · see citing works

The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma

Pfister, S. M., Rea, S., Taipale, M., Mendrzyk, F., Straub, B. K., Ittrich, C., Olaf, T., Sinn, H., Akhtar, A., & Lichter, P. (2007) · International Journal of Cancer · doi:10.1002/ijc.23283 · Cited by 167 · see citing works

Protein N-terminal acetyltransferases in cancer

Kalvik, T. V., & Arnesen, T. (2012) · Oncogene · doi:10.1038/onc.2012.82 · Cited by 159 · see citing works

MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells

Yang, X.-J., & Ullah, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210609 · Cited by 152 · see citing works

p300 Modulates the BRCA1 inhibition of estrogen receptor activity.

Fan, S., Ma, Y. X., Wang, C., Yuan, R., Meng, Q., Wang, J., Erdos, M. R., Goldberg, I. D., Webb, P., Kushner, P. J., et al. (2002) · PubMed · Cited by 148 · see citing works

Epigenetic Multiple Ligands: Mixed Histone/Protein Methyltransferase, Acetyltransferase, and Class III Deacetylase (Sirtuin) Inhibitors

Mai, A., Cheng, D., Bedford, M. T., Valente, S., Nebbioso, A., Perrone, A., Brosch, G., Sbardella, G., Bellis, F. D., Miceli, M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701595q · Cited by 136 · see citing works

Metabolic regulation by SIRT3: implications for tumorigenesis

Finley, L. W. S., & Haigis, M. C. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.05.004 · Cited by 130 · see citing works

High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma

Li, M., Luo, R.-Z., Chen, J.-W., Cao, Y., Lu, J.-B., He, J., Wu, Q., & Cai, M.-Y. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-5 · Cited by 127 · see citing works

Reversible acetylation of chromatin: Implication in regulation of gene expression, disease and therapeutics

Selvi, R. B., & Kundu, T. K. (2009) · Biotechnology Journal · doi:10.1002/biot.200900032 · Cited by 120 · see citing works

Tuning acetylation levels with HAT activators: Therapeutic strategy in neurodegenerative diseases

Selvi, B. R., Cassel, J., Kundu, T. K., & Boutillier, A. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.08.012 · Cited by 117 · see citing works

Curcumin Enhances the Efficacy of Chemotherapy by Tailoring p65NFκB-p300 Cross-talk in Favor of p53-p300 in Breast Cancer

Sen, G. S., Mohanty, S., Hossain, D. M. S., Bhattacharyya, S., Banerjee, S., Chakraborty, J., Saha, S., Ray, P., Bhattacharjee, P., Mandal, D. P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262295 · Cited by 107 · see citing works

A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells

Ahn, M. Y., Jung, J. H., Na, Y. J., & Kim, H. S. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.098 · Cited by 102 · see citing works

Histone Modifications in Cancer Biology and Prognosis

Kurdistani, S. K. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_5 · Cited by 102 · see citing works

New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas

LLeonart, M. E., Vidal, F., Gallardo, D., Díaz-Fuertes, M., Rojo, F., Cuatrecasas, M., López-Vicente, L., Kondoh, H., Blanco, C., Carnero, A., et al. (2006) · Oncology Reports · doi:10.3892/or.16.3.603 · Cited by 99 · see citing works

ChromoHub: a data hub for navigators of chromatin-mediated signalling

Liu, L., Zhen, X. T., Denton, E., Marsden, B. D., & Schapira, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts340 · Cited by 95 · see citing works

Global histone acetylation levels: Prognostic relevance in patients with renal cell carcinoma

Mosashvilli, D., Kahl, P., Mertens, C., Holzapfel, S., Rogenhofer, S., Hauser, S., Büttner, R., von Ruecker, A., Müller, S. C., & Ellinger, J. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01717.x · Cited by 94 · see citing works

A dual role of linker histone H1.4 Lys 34 acetylation in transcriptional activationPreprint

Kamieniarz, K., Izzo, A., Dundr, M., Tropberger, P., Ozretić, L., Kirfel, J., Scheer, E., Tropel, P., Wiśniewski, J. R., Tora, L., et al. (2012) · Genes & Development · doi:10.1101/gad.182014.111 · Cited by 93 · see citing works

Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressorPreprint

Liu, X., & Marmorstein, R. (2007) · Genes & Development · doi:10.1101/gad.1590607 · Cited by 92 · see citing works

Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene

Singh, S. A., Isken, F., Agelopoulos, K., Klein, H., Thoennissen, N. H., Koehler, G., Hascher, A., Bäumer, N., Berdel, W. E., Thiede, C., et al. (2011) · Blood · doi:10.1182/blood-2011-06-358705 · Cited by 86 · see citing works

High expression of p300 in human breast cancer correlates with tumor recurrence and predicts adverse prognosis

Xiao, X.-S., Cai, M.-Y., Chen, J.-W., Guan, X., Kung, H., Zeng, Y.-X., & Xie, D. (2011) · Chinese Journal of Cancer Research · doi:10.1007/s11670-011-0201-5 · Cited by 84 · see citing works

Prognostic impact of Skp2 and p27 in human breast cancer

Traub, F., Mengel, M., Lück, H. J., Kreipe, H. H., & von Wasielewski, R. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9202-3 · Cited by 80 · see citing works

Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation

Rozman, M., Camós, M., Colomer, D., Villamor, N., Esteve, J., Costa, D., Carrió, A., Aymerich, M., Aguilar, J. L., Domingo, A., et al. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20022 · Cited by 79 · see citing works

HDAC modulation and cell death in the clinic

Dell’Aversana, C., Lepore, I., & Altucci, L. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.01.025 · Cited by 61 · see citing works

Implications of small molecule activators and inhibitors of histone acetyltransferases in chromatin therapy

Varier, R. A., Swaminathan, V., Balasubramanyam, K., & Kundu, T. K. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.038 · Cited by 52 · see citing works

High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers

Hou, X., Li, Y., Luo, R., Fu, J., He, J., Zhang, L., & Yang, H.-X. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2012.02.180 · Cited by 52 · see citing works

Going global: Novel histone modifications in the globular domain of H3

Tropberger, P., & Schneider, R. (2010) · Epigenetics · doi:10.4161/epi.5.2.11075 · Cited by 46 · see citing works

Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis

Diab, A. K., Zickl, L., Abdel-Wahab, O. I., Jhanwar, S. C., Gulam, M. A., Panageas, K. S., Patel, J. P., Jurcic, J. G., Maslak, P. G., Paietta, E. M., et al. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.08.025 · Cited by 33 · see citing works

Tip60 Protein Isoforms and Altered Function in Skin and Tumors that Overexpress Ornithine Decarboxylase

Hobbs, C. A., Wei, G., DeFeo, K., Paul, B. A., Hayes, C. S., & Gilmour, S. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0359 · Cited by 32 · see citing works

Tuning acetylated chromatin with HAT inhibitors: A novel tool for therapy

Vernarecci, S., Tosi, F., & Filetici, P. (2010) · Epigenetics · doi:10.4161/epi.5.2.10942 · Cited by 18 · see citing works

Concurrent translocations ofMLL andCBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia

Mathew, S., Head, D., Rubnitz, J. E., & Raimondi, S. C. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200006)28:2 · Cited by 16 · see citing works

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097 · see citing works

Histone Modifications and CancerPreprint

Audia, J. E., & Campbell, R. M. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019521 · Cited by 1,024 · see citing works

Towards targeting of shared mechanisms of cancer metastasis and therapy resistance

Weiß, F., Lauffenburger, D. A., & Friedl, P. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-021-00427-0 · Cited by 294 · see citing works

The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer

Spangle, J. M., Roberts, T. M., & Zhao, J. J. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.002 · Cited by 169 · see citing works

Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation

Gong, F., & Miller, K. M. (2013) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2013.07.002 · Cited by 171 · see citing works

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance

Sadida, H. Q., Abdulla, A., Marzooqi, S. A., Hashem, S., Macha, M. A., Akil, A. S. A.-S., & Bhat, A. A. (2024) · Translational Oncology · doi:10.1016/j.tranon.2023.101821 · Cited by 151 · see citing works

Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer

Gong, F., Chiu, L.-Y., & Miller, K. M. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006272 · Cited by 132 · see citing works

Measurement of acetylation turnover at distinct lysines in human histones identifies long-lived acetylation sites

Zheng, Y., Thomas, P. M., & Kelleher, N. L. (2013) · Nature Communications · doi:10.1038/ncomms3203 · Cited by 115 · see citing works

Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma

Hu, X., Martínez-Ledesma, E., Zheng, S., Kim, H., Barthel, F. P., Jiang, T., Hess, K. R., & Verhaak, R. G. W. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now285 · Cited by 114 · see citing works

Targeting post-translational histone modifying enzymes in glioblastoma

Kunadis, E., Lakiotaki, E., Korkolopoulou, P. A., & Piperi, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107721 · Cited by 111 · see citing works

The recent insights into the function of ACAT1: A possible anti-cancer therapeutic target

Goudarzi, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116592 · Cited by 101 · see citing works

Targeting p38 MAP kinase signaling in cancer through post-translational modifications

Zou, X., & Blank, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.008 · Cited by 102 · see citing works

Preserving genome integrity and function: the DNA damage response and histone modifications

Kim, J. J., Lee, S. Y., & Miller, K. M. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1620676 · Cited by 95 · see citing works

A novel histone H4 variant H4G regulates rDNA transcription in breast cancer

Long, M., Sun, X., Shi, W., An, Y., Leung, S. T. C., Ding, D., Cheema, M. S., Macpherson, N. A., Nelson, C. J., Ausió, J., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz547 · Cited by 81 · see citing works

Acetylation and deacetylation in cancer stem-like cells

Liu, N., Li, S., Wu, N., & Cho, K. (2017) · Oncotarget · doi:10.18632/oncotarget.19167 · Cited by 81 · see citing works

Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside

Pajares, M. J., Alemany-Cosme, E., Goñi, S., Bandrés, E., Palanca-Ballester, C., & Sandoval, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147350 · Cited by 82 · see citing works

Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy

Wu, D., Qiu, Y., Jiao, Y., Qiu, Z., & Liu, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.560487 · Cited by 81 · see citing works

An efficient and multiple target transgenic RNAi technique with low toxicity in Drosophila

Qiao, H., Wang, F., Xu, R., Sun, J., Zhu, R., Mao, D., Ren, X., Wang, X., Jia, Y., Peng, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06537-y · Cited by 74 · see citing works

Identification of lysine isobutyrylation as a new histone modification mark

Zhu, Z., Han, Z. H., Halabelian, L., Yang, X., Ding, J., Zhang, N., Ngo, L., Song, J., Zeng, H., He, M., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1176 · Cited by 74 · see citing works

The Vitamin D Receptor Inhibits the Respiratory Chain, Contributing to the Metabolic Switch that Is Essential for Cancer Cell Proliferation

Consiglio, M., Destefanis, M., Morena, D., Foglizzo, V., Forneris, M., Pescarmona, G., & Silvagno, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115816 · Cited by 74 · see citing works

Role of Flavonoids as Epigenetic Modulators in Cancer Prevention and Therapy

Fatima, N., Baqri, S. S. R., Bhattacharya, A., Koney, N. K., Husain, K. M., Abbas, A., & Ansari, R. A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.758733 · Cited by 64 · see citing works

Functional Roles of Bromodomain Proteins in Cancer

Boyson, S. P., Gao, C., Quinn, K. M., Boyd, J. R., Paculová, H., Frietze, S. E., & Glass, K. C. (2021) · Cancers · doi:10.3390/cancers13143606 · Cited by 58 · see citing works

Beyond genetics: Exploring the role of epigenetic alterations in breast cancer

Prabhu, K. S., Sadida, H. Q., Kuttikrishnan, S., Junejo, K., Bhat, A. A., & Shahab Uddin, M. S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155174 · Cited by 53 · see citing works

Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma

Chai, P., Jia, R., Li, Y., Zhou, C., Gu, X., Yang, L., Shi, H., Tian, H., Lin, H., Yu, J., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101030 · Cited by 52 · see citing works

New mechanism of LncRNA: In addition to act as a ceRNA

Zhang, J., Zhu, H., Li, L., Gao, Y., Yu, B., Ma, G., Jin, X., & Sun, Y. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.06.002 · Cited by 51 · see citing works

Acetylation of histone H3 in cancer progression and prognosis

Miziak, P., Baran, M., Borkiewicz, L., Trombik, T., & Stepulak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010982 · Cited by 49 · see citing works

Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures

Oberhofer, A., Bronkhorst, A. J., Uhlig, C., Ungerer, V., & Holdenrieder, S. (2022) · Diagnostics · doi:10.3390/diagnostics12081834 · Cited by 45 · see citing works

Bromodomain proteins: repairing DNA damage within chromatin

Chiu, L.-Y., Gong, F., & Miller, K. M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0286 · Cited by 47 · see citing works

Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer

Oh, J. H., Lee, J., Kim, K. H., Kim, C. Y., Jeong, D. S., Cho, Y., Nam, K. T., & Kim, M. H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.09.017 · Cited by 47 · see citing works

The persistent organochlorine pesticide endosulfan modulates multiple epigenetic regulators with oncogenic potential in MCF-7 cells

Ghosh, K. K., Chatterjee, B., Jayaprasad, A. G., & Kanade, S. R. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.10.058 · Cited by 45 · see citing works

Nonenzymatic Protein Acetylation Detected by NAPPA Protein Arrays

Olia, A. S., Barker, K., McCullough, C. E., Tang, H., Speicher, D. W., Qiu, J., LaBaer, J., & Marmorstein, R. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00342 · Cited by 44 · see citing works

Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments

Martínez‐Useros, J., Martin-Galan, M., Florez-Cespedes, M., & García‐Foncillas, J. (2021) · Cancers · doi:10.3390/cancers13133209 · Cited by 44 · see citing works

Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer

Senapati, P., Kato, H., Lee, M., Leung, A., Thai, C., Sanchez, A., Gallagher, E. J., LeRoith, D., Seewaldt, V. L., Ann, D. K., et al. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0290-9 · Cited by 42 · see citing works

The remodel of the “central dogma”: a metabolomics interaction perspective

dos Santos, G. C., Renovato‐Martins, M., & de Brito, N. M. (2021) · Metabolomics · doi:10.1007/s11306-021-01800-8 · Cited by 41 · see citing works

The many metabolic sources of acetyl-CoA to support histone acetylation and influence cancer progression

Féron, O. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.140 · Cited by 38 · see citing works

MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications

Szczepanek, J., & Tretyn, A. (2023) · Biomolecules · doi:10.3390/biom13111590 · Cited by 40 · see citing works

Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer

Shukla, H. D. (2017) · Proteomes · doi:10.3390/proteomes5040028 · Cited by 40 · see citing works

Epigenetic modulation of BRCA‐1 and MGMT genes, and histones H4 and H3 are associated with breast tumors

Paydar, P., Asadikaram, G., Nejad, H. Z., Akbari, H., Abolhassani, M., Moazed, V., Nematollahi, M. H., Ebrahimi, G., & Fallah, H. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28645 · Cited by 40 · see citing works

Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review

Ali, S. R., Humphreys, K. J., McKinnon, R. A., & Michael, M. (2015) · Drug Development Research · doi:10.1002/ddr.21268 · Cited by 39 · see citing works

Garcinol, an Acetyltransferase Inhibitor, Suppresses Proliferation of Breast Cancer Cell Line MCF-7 Promoted by 17β-Estradiol

Ye, X., Yuan, L., Zhang, L., Zhao, J., Zhang, C., & Deng, H. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.12.5001 · Cited by 39 · see citing works

Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach

Ranganna, K., Selvam, C., Shivachar, A. C., & Yousefipour, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218198 · Cited by 39 · see citing works

Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening

Kumar, V., Lakshman, P. K. C., Prasad, T. K., Manjunath, K., Bairy, S. G., Vasu, A. S., Ganavi, B., Jasti, S., & Kamariah, N. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23864 · Cited by 40 · see citing works

Epigenetic Properties of Compounds Contained in Functional Foods Against Cancer

Casari, G., Romaldi, B., Scirè, A., Minnelli, C., Marzioni, D., Ferretti, G., & Armeni, T. (2024) · Biomolecules · doi:10.3390/biom15010015 · Cited by 37 · see citing works

Role of Histone Acetylation in Gastric Cancer: Implications of Dietetic Compounds and Clinical Perspectives

Calcagno, D. Q., Wisnieski, F., Mota, E. R. D. S., de Sousa, S. B. M., da Silva, J. M. C., Leal, M. F., Gigek, C. O., Santos, L. C., Rasmussen, L. T., de Assumpção, P. P., et al. (2019) · Epigenomics · doi:10.2217/epi-2018-0081 · Cited by 36 · see citing works

The impact of CBP expression in estrogen receptor-positive breast cancer

Ramadan, W. S. H., Talaat, I. M., Hachim, M. Y., Lischka, A., Gemoll, T., & El‐Awady, R. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01060-2 · Cited by 36 · see citing works

The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors

Lobo, J., Henrique, R., & Jerónimo, C. (2018) · Cancers · doi:10.3390/cancers11010006 · Cited by 35 · see citing works

Histone H4 variant, H4G, drives ribosomal RNA transcription and breast cancer cell proliferation by loosening nucleolar chromatin structure

Pang, M. Y. H., Sun, X., Ausió, J., & Ishibashi, T. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29770 · Cited by 35 · see citing works

Chemical Catalysis Intervening to Histone Epigenetics

Nozaki, T., & Kanai, M. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00144 · Cited by 34 · see citing works

Regulation of Thermogenic Adipocyte Differentiation and Adaptive Thermogenesis Through Histone Acetylation

Ong, B. X., Brunmeir, R., Zhang, Q., Xu, P., Idris, M., Liu, C., & Xu, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00095 · Cited by 33 · see citing works

Curcumin's prevention of inflammation-driven early gastric cancer and its molecular mechanism

Zhang, W., Cui, N., Ye, J., Yang, B., Sun, Y., & Kuang, H. (2022) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2021.11.003 · Cited by 31 · see citing works

Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in Cancer

Noberini, R., Restellini, C., Savoia, E. O., Raimondi, F., Ghiani, L., Jodice, M. G., Bertalot, G., Bonizzi, G., Capra, M. C., Maffini, F. A., et al. (2019) · Cancers · doi:10.3390/cancers11050723 · Cited by 29 · see citing works

Targeting histone modifiers in bladder cancer therapy — preclinical and clinical evidence

Zhang, S., Lin, T., Xiong, X., Chen, C., Tan, P., & Wei, Q. (2024) · Nature Reviews Urology · doi:10.1038/s41585-024-00857-z · Cited by 30 · see citing works

Recent advances in biosensor for histone acetyltransferase detection

Chen, Y., Zhou, Y., & Yin, H. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112880 · Cited by 28 · see citing works

Site-Selective Synthetic Acylation of a Target Protein in Living Cells Promoted by a Chemical Catalyst/Donor System

Hamajima, W., Fujimura, A., Fujiwara, Y., Yamatsugu, K., Kawashima, S. A., & Kanai, M. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00102 · Cited by 27 · see citing works

Epigenetic regulation of prostate cancer

Wang, R., & Liu, X. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.10.018 · Cited by 27 · see citing works

ACAT1-mediated METTL3 acetylation inhibits cell migration and invasion in triple negative breast cancer

Zhang, G., Huang, R., Zhao, H., Xia, Y., Huang, H., Qian, M., Fu, Y., & Cui, Y. (2023) · Genes and Immunity · doi:10.1038/s41435-023-00202-1 · Cited by 27 · see citing works

Genetic dysregulation of EP300 in cancers in light of cancer epigenome control – targeting of p300-proficient and -deficient cancers

Gronkowska, K., & Robaszkiewicz, A. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200871 · Cited by 26 · see citing works

The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens

Ribeiro, E., & Vale, N. (2024) · Targets · doi:10.3390/targets2040018 · Cited by 28 · see citing works

Luteolin Causes 5′CpG Demethylation of the Promoters of TSGs and Modulates the Aberrant Histone Modifications, Restoring the Expression of TSGs in Human Cancer Cells

Pramodh, S., Raina, R., Hussain, A., Bagabir, S. A., Haque, S., Raza, S. T., Ajmal, M. R., Behl, S., & Bhagavatula, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074067 · Cited by 26 · see citing works

Epigenetic regulation of RTK signaling

Spangle, J. M., & Roberts, T. M. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1546-0 · Cited by 26 · see citing works

Unlocking the epigenetic code: new insights into triple-negative breast cancer

Mahendran, G., Shangaradas, A. D., Romero-Moreno, R., Dona, N. W., Sarasija, S. H. G. S., Perera, S., & Silva, G. N. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1499950 · Cited by 25 · see citing works

AML associated oncofusion proteins PML-RARA, AML1-ETO and CBFB-MYH11 target RUNX/ETS-factor binding sites to modulate H3ac levels and drive leukemogenesis

Singh, A. A., Mandoli, A., Prange, K. H. M., Laakso, M., & Martens, J. H. A. (2016) · Oncotarget · doi:10.18632/oncotarget.14150 · Cited by 26 · see citing works

Cancer plasticity: Investigating the causes for this agility

Saha, S., Pradhan, N., Neha, B., Mahadevappa, R., Minocha, S., & Kumar, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.005 · Cited by 25 · see citing works

Epigenetic Dysregulation in Cancer: Implications for Gene Expression and DNA Repair-Associated Pathways

Rembiałkowska, N., Rekiel, K., Urbanowicz, P., Mamala, M. B., Marczuk, K. M., Wojtaszek, M., Żywica, M., Radzevičiūtė-Valčiukė, E., Novickij, V., & Kulbacka, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136531 · Cited by 24 · see citing works

Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors

Xiong, Y., Zhang, M., & Li, Y. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190731141055 · Cited by 23 · see citing works

Synergistic targeting strategies for prostate cancer

Li, X., Han, Z., & Ai, J. (2025) · Nature Reviews Urology · doi:10.1038/s41585-025-01042-6 · Cited by 21 · see citing works

CDKN1A histone acetylation and gene expression relationship in gastric adenocarcinomas

Wisnieski, F., Calcagno, D. Q., Leal, M. F., Santos, L. C., Gigek, C. O., Chen, E., Demachki, S., Artigiani, R., de Assumpção, P. P., Lourenço, L. G., et al. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0400-3 · Cited by 21 · see citing works

Introduction to Epigenetics

Paro, R., Grossniklaus, U., Santoro, R., & Wutz, A. (2021) · Learning materials in biosciences · doi:10.1007/978-3-030-68670-3 · Cited by 21 · see citing works

Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy

Myasoedova, V. A., Sukhorukov, V. N., Grechko, A. V., Zhang, D., Romanenko, E. B., Orekhov, V., & Orekhov, A. N. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190405144026 · Cited by 20 · see citing works

Alterations of Histone Modifications in Cancer

Hosseini, A., & Minucci, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00006-6 · Cited by 20 · see citing works

Histone acetyltransferases as promising therapeutic targets in glioblastoma resistance

Pathikonda, S., Amirmahani, F., Mathew, D., & Muthukrishnan, S. D. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217269 · Cited by 19 · see citing works

Targeting epigenetic regulation for cancer therapy using small molecule inhibitors

Kumar, A., Emdad, L., Fisher, P. B., & Das, S. K. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.01.001 · Cited by 19 · see citing works

Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma

Rodney, A. R., Skidmore, Z. L., Grenier, J. K., Griffith, O. L., Miller, A. D., Chu, S., Ahmed, F., Bryan, J. N., Peralta, S., & Warren, W. C. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1079019 · Cited by 19 · see citing works

A quantitative multiplexed mass spectrometry assay for studying the kinetic of residue-specific histone acetylation

Kuo, Y., Henry, R. A., & Andrews, A. J. (2014) · Methods · doi:10.1016/j.ymeth.2014.08.003 · Cited by 19 · see citing works

Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy

Zheng, T., Wang, S., Liu, W., & Lu, Y. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02613 · Cited by 18 · see citing works

An Assessment on Ethanol-Blended Gasoline/Diesel Fuels on Cancer Risk and Mortality

Mueller, S., Dennison, G., & Liu, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18136930 · Cited by 18 · see citing works

Histone lysine modifying enzymes and their critical roles in DNA double-strand break repair

Zhang, J., Lu, X., MoghaddamKohi, S., Shi, L., Xu, X., & Zhu, W. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103206 · Cited by 18 · see citing works

RNAi screening identifies KAT8 as a key molecule important for cancer cell survival.

Zhang, S., Liu, X., Zhang, Y., Cheng, Y., & Li, Y. (2013) · Europe PMC (PubMed Central) · Cited by 18 · see citing works

Targeting apoptosis in clear cell renal cell carcinoma

Kowalewski, A., Borowczak, J., Maniewski, M., Gostomczyk, K., Grzanka, D., & Szylberg, Ł. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116805 · Cited by 18 · see citing works

Aflatoxin B1 induced multiple epigenetic modulators in human epithelial cell lines

Soni, P., Ghufran, M. S., & Kanade, S. R. (2018) · Toxicon · doi:10.1016/j.toxicon.2018.07.011 · Cited by 17 · see citing works

HAT1: Landscape of Biological Function and Role in Cancer

Capone, V., Torre, L. D., Carannante, D., Babaei, M., Altucci, L., Benedetti, R., & Carafa, V. (2023) · Cells · doi:10.3390/cells12071075 · Cited by 17 · see citing works

Histone and Histone Acetylation-Related Alterations of Gene Expression in Uninvolved Psoriatic Skin and Their Effects on Cell Proliferation, Differentiation, and Immune Responses

Romhányi, D., Szabó, K., Kemény, L. V., & Groma, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914551 · Cited by 16 · see citing works

Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells

Najem, S. A., Khawaja, G., Hodroj, M. H., Babikian, P., & Rizk, S. E. (2019) · Cells · doi:10.3390/cells8121480 · Cited by 16 · see citing works

Single-Cell Epigenomics in Cancer: Charting a Course to Clinical Impact

Bond, D. R., Uddipto, K., Enjeti, A. K., & Lee, H. J. (2020) · Epigenomics · doi:10.2217/epi-2020-0046 · Cited by 15 · see citing works

The dysregulation of lncRNAs by epigenetic factors in human pathologies

Zhang, Y., Wang, X., Zhang, C., & Yi, H. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103664 · Cited by 14 · see citing works

Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies

Schütte, J., Reusch, J., Khandanpour, C., & Eisfeld, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00839 · Cited by 14 · see citing works

Bioorthogonal Reporters for Detecting and Profiling Protein Acetylation and Acylation

Song, J., & Zheng, Y. G. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219887144 · Cited by 14 · see citing works

Interaction of cervical microbiome with epigenome of epithelial cells: Significance of inflammation to primary healthcare

Holubeková, V., Kolková, Z., Kašubová, I., Samec, M., Mazuráková, A., Koklesová, L., Kubatka, P., Rokos, T., Kozubík, E., Biringer, K., et al. (2022) · BioMolecular Concepts · doi:10.1515/bmc-2022-0005 · Cited by 13 · see citing works

Epigenetic Modifications, Chromatin Distribution and TP53 Transcription in a Model of Breast Cancer Progression

dos Santos, G. C., da Silva, A. P., Feldman, L., Ventura, G. M., Vassetzky, Y. S., & Gallo, C. V. D. M. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25003 · Cited by 13 · see citing works

Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation

Hutt, D. M., Roth, D., Marchal, C., & Bouchecareilh, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6527-4_6 · Cited by 13 · see citing works

Basic science: Epigenetic programming and the respiratory system

Durham, A. L., & Adcock, I. M. (2013) · Breathe · doi:10.1183/20734735.000413 · Cited by 12 · see citing works

Roles of Lipids in Cancer

Lim, J. Y., & Kwan, H. Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80788 · Cited by 12 · see citing works

Patent Spotlight: small-molecule Lysine Acetyltransferase Inhibitors (KATi)

Brown, J. A. L. (2020) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2019-0025 · Cited by 12 · see citing works

Human papillomavirus-mediated cervical cancer: epigenetic interplay and clinical implications

Sisodiya, S., Singh, P., Joshi, T., Aftab, M., Firdausi, N., Khan, A., Mishra, N., Khan, N. J., Tanwar, P., Gupta, V., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1633283 · Cited by 11 · see citing works

Rpb9-deficient cells are defective in DNA damage response and require histone H3 acetylation for survival

Sein, H., Reinmets, K., Peil, K., Kristjuhan, K., Värv, S., & Kristjuhan, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-21110-9 · Cited by 11 · see citing works

Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis

Xie, L., Wu, S., He, R. X., Li, S., Lai, X., & Wang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901662 · Cited by 11 · see citing works

The Expression of Histone Acetyltransferase KAT6A in Non-small Cell Lung Cancer

Partyńska, A., Piotrowska, A., Pawełczyk, K., Rzechonek, A., Ratajczak‐Wielgomas, K., Podhorska‐Okołów, M., & Dzięgiel, P. (2022) · Anticancer Research · doi:10.21873/anticanres.16080 · Cited by 11 · see citing works

The landscape of histone acetylation involved in epithelial-mesenchymal transition in lung cancer

Liu, Z., Zhang, L., Ma, W., & Wang, B. (2013) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.119113 · Cited by 10 · see citing works

A Mini Review on Post-Translational Histone Modifications

SÜT, B. B. (2016) · MOJ Cell Science & Report · doi:10.15406/mojcsr.2016.03.00047 · Cited by 10 · see citing works

Post-Translational Modifications of Histone Variants in the Absence and Presence of a Methionine-Depleting Enzyme in Normal and Cancer Cells

Montalbano, S., Raboni, S., Sidoli, S., Mozzarelli, A., Bettati, S., & Buschini, A. (2023) · Cancers · doi:10.3390/cancers15020527 · Cited by 9 · see citing works

Histone Acetyltransferases in Cancer: Guardians or Hazards?

Demetriadou, C., & Kirmizis, A. (2017) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2017024506 · Cited by 27 · see citing works

HAT inhibitors in cancer therapy

Fiorentino, F., Mai, A., & Rotili, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816422-8.00003-9 · Cited by 4 · see citing works

A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy

Ghanbari, M., Safaralizadeh, R., & Mohammadi, K. (2018) · Current Cancer Therapy Reviews · doi:10.2174/1573394714666180720152100 · Cited by 7 · see citing works

Biological functions and therapeutic potential of acylation by histone acetyltransferases

Li, N., Hamor, C., An, Y., Zhu, L., Gong, Y., Toh, Y., & Guo, Y. R. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0010 · Cited by 10 · see citing works

HAT1: Landscape of Biological Function and Role in Cancer

Capone, V., Torre, L. D., Carannante, D., Babaei, M., Altucci, L., Benedetti, R., & Carafa, V. (2023) · Cells · doi:10.3390/cells12071075 · Cited by 17 · see citing works